You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
TRIAGE HF™ is designed to integrate the diagnostic data collected by the compatible cardiac implanted device and provide an overall heart failure risk assessment. The risk assessment is based on an analysis of the cardiac device diagnostic data from the previous 30 days to calculate the probability of a heart failure event within the next 30 days.
OptiVol™, Patient Activity, AT/AF Burden, Ventricular Rate during AT/AF, % Ventricular Pacing, Shocks, Treated VT/VF, Night Ventricular Rate, Heart Rate Variability.
TriageHF™-enabled clinics can leverage the technology for all CIED* patients with OptiVol™, with backward compatibility.
Hazard Ratio 10x
Hazard Ratio 2.1x
Neg Pred Value 99.4%
Prof. Haran Burri (Geneva)
Compatible with most OptiVol™-enabled devices. Please contact your local Medtronic sales representative for a complete list.
Heart Failure Society of America (HFSA) 22nd Annual Scientific Meeting. “What Do Heart Failure Patients Really Want, and Do Doctors Get it?” - Medscape Medical News - Nov 06, 2018. Available on-line at https://www.medscape.com/viewarticle/904440
Medtronic CareLink™ Heart Failure Risk Status Technical Manual M945636A001 A.
Cowie MR, et al. Eur Heart J. 2013;34:2472-2480.